Objectives: We sought to describe the phenotype for patients with P.I.G. including presentation, evaluation, cardiac co-morbidities, high resolution computed tomography findings, and outcomes.
A large, multi-center retrospective clinical and histologic review of lung biopsies from children with diffuse lung disease classified P.I.G. as a distinct entity more common in infancy with an unknown etiology. 4 Since these early descriptions, infants with P.I.G. have been reported around the world, including in twins. 5 Common features to these reports include presentation in the infant period (under 9 months of age) with hypoxemia and respiratory distress. Co-associations with alveolar simplification and structural heart disease have been described. 3, 4, 6 The diagnostic gold standard is lung biopsy. 7 Many infants with P.I.G. have received therapeutic trials of glucocorticoids with anecdotal positive responses. 6 Outcomes have overall been
favorable, but few data on long term follow-up exist, with the longest being 6 years. 2, 4, 8 Our aim was to more completely characterize the clinical, radiological, and histological spectrum of P.I.G. and to describe treatment approaches and long term outcomes.
| MATERIALS AND METHODS
With institutional review board approval for which informed consent was waived, we performed a single-center retrospective review of patients with biopsy-proven P.I.G. evaluated at Children's Hospital
Colorado before 5/30/2015. The earliest patient included was born in 2001. Patients were identified from a rare lung disease patient registry as well as a search through Informatics for Integrating Biology and the Bedside (i2b2). Three patients in this cohort were included in a previous study. 4 Chart review was performed to gather data.
Comorbidities were determined by problem lists and chart review.
Structural heart disease and pulmonary hypertension were identified by echocardiogram (JRD). The echocardiogram closest to lung biopsy was included. Cardiac catheterization, when available, was used to assess degree of pulmonary hypertension. Infants born at a recorded "full term" were considered to be born at 39 weeks for statistical analysis. Response to steroids was determined by clinician report and notation in the chart. Biopsies were characterized as having patchy versus diffuse findings of P.I.G., alveolar simplification, and pulmonary artery changes (arterial media thickening with increased smooth muscle cells) by a pediatric pathologist with expertise in pediatric lung pathology and chILD (MKD and CG). A pediatric radiologist with expertise in chest radiology and chILD (JPW) reviewed each high resolution chest computed tomography scan (HRCT) and applied a standardized score. Categorical outcomes are presented as frequencies (n) and percentages (%). Logistic regression was used to assess an association of age with findings on lung biopsy (patchy vs diffuse as the outcome). All P-values <0.05 were considered statistically significant. All calculations were done using SAS software version 9.4 (SAS Institute, Cary, NC).
| RESULTS
Demographics are described in detail in Table 3 . The most common primary HRCT findings were ground glass opacities (GGO) (13 patients), followed by linear reticular opacities (three patients). The most common secondary CT findings were cysts (six patients) followed by GGO (five patients). The most common CT findings overall (primary, secondary, and tertiary) were GGO (19 patients), followed by cysts (11 patients). Typical HRCT findings of GGO and cysts are shown in Figure 1 . Most of the HRCT findings were diffuse, however some were localized.
Three patients had subsequent HRCT scans. One patient had
HRCTs at 18 days, 1 year, and 9 years. This patient initially had air trapping primary in the left upper lobe which evolved to linear reticular opacities in the right upper lobe and right lower lobe as well as and subsequently showed cysts and decreased but persistent GGO.
| Biopsy findings
The median age of lung biopsy was 7 weeks (IQR: 4-13) after birth.
Median corrected gestational age at biopsy was 76 weeks (IQR: 65-80).
Two of the biopsies were not available for review; these patients presented to our center for second opinions. Respiratory support at the time of biopsy ranged from extracorporeal membrane oxygenation to oxygen via nasal cannula. One patient required extracorporeal membrane oxygenation, one was treated with high frequency oscillatory ventilation, 10 were mechanically ventilated, one was non-invasively ventilated, three were treated with heated humidified high flow nasal cannula, and four were treated with nasal cannula oxygen. Four had unknown respiratory support at the time of the biopsy. Pathology findings are summarized in Table 4 .
Forty-six percent of all biopsies revealed patchy disease (n = 11); 46% revealed diffuse disease (n = 11); two biopsies were unknown. 
| Cardiology findings
Nine of 19 patients who had echocardiograms at Children's Hospital
Colorado demonstrated some degree of pulmonary hypertension.
Nine patients underwent cardiac catheterization, four of whom had severe congenital heart disease: (HLHS or variant [2] , pulmonary vein stenosis [1] , and pulmonary valve atresia [1] 
| Treatment
Respiratory support ranged from extracorporeal membrane oxygenation (n = 3) to nasal cannula (n = 3), as shown in Table 2 . Seventy-one percent of patients required either invasive or non-invasive ventilation (n = 17). By the time of hospital discharge, most patients required nasal cannula oxygen, although two weaned off all support and eight were discharged on mechanical ventilation.
Nearly all patients (92%; n = 22) were treated with systemic corticosteroids, either orally, intravenously, or both. Ten patients were treated with systemic corticosteroids before the biopsy. Sixteen were treated with systemic corticosteroids after the biopsy. Three patients were felt to have an excellent clinical response to steroids as reported in the medical records by the care teams. Quantifying the clinical response to steroids was not possible.
Two patients were found to aspirate (out of 15 evaluated) by videofluoroscopic study or upper gastrointestinal series. Thirteen patients had a gastrostomy tube, and the majority of those with gastrostomy tubes underwent fundoplications (n = 10).
| Outcomes
Median age at last follow-up was about 3 years (1234 days) with a range of 37 days to 15 years. At the time of last follow-up, 12 patients with comorbid chronic lung disease of prematurity, pulmonary hypertension, and/or structural heart disease. Many patients in our cohort suffered from a variety of additional co-morbidities which may be secondary to underlying genetic syndromes. We did not note any associated with congenital lung malformations, although we did not review all biopsies of patients with congenital lung malformations to determine if P.I.G. may have been present and missed as has been presented in other series. 11 We do not have lung tissue on all patients with structural heart disease or at every gestational age to better understand the prevalence of P.I.G in populations such as congenital heart disease or prematurity. Understanding this phenotype will help clinicians evaluate infants with unexplained respiratory distress or failure, especially in late pre-term or term infants with comorbid cardiac disease. P.I.G. may be overlooked in patients who never undergo lung biopsy; CT can suggest P.I.G. with cysts and GGO, but clinicians should suspect P.I.G. in infants with respiratory requirements out of proportion to their gestational age.
Few lung biopsies are performed in patients born prior to 28 weeks gestational age. In the current study, younger patients had more diffuse disease on biopsy, suggesting that P.I.G. could be part of normal lung development that improves over time. Most patients in the current study had alveolar simplification seen in association with P.I.G. In a larger series of patients with diffuse lung disease, P.I.G. was recognized as the primary diagnosis in six patients and as a secondary diagnosis in 19 patients with alveolar simplification. 4 It is unknown if the P.I.G. precedes or follows structural developmental defects. It is also unknown if the P.I.G. cells interfere with normal structural development or are part of normal development.
HRCT findings, which were not previously described in detail, are typically characterized by GGO with cystic changes. We believe that the cystic regions correlate with areas of alveolar simplification on biopsy and are therefore likely not true cysts. Radiographic findings differ between bronchopulmonary dysplasia and P.I.G. CT findings in bronchopulmonary dysplasia typically consist of cystic changes indicating an alveolar growth abnormality, 12 however, in P.I.G., GGO were observed in the majority of our patients. As GGO and cysts on CT scans may suggest a surfactant dysfunction mutation, laboratory testing for these mutations may be appropriate prior to pursuing lung biopsy. 7 Three of our patients had repeat CTs; in two patients, the ground glass opacities resolved while the cysts persisted. Though follow-up CTs were limited, this resolution of GGO corroborates our working hypothesis that P.I.G. improves over time while the changes consistent with alveolar simplification may persist. A third patient had persistent left upper lobe air trapping that persisted over time. In our experience, the CT findings of GGO and cystic changes are typical, but not pathognomonic for P.I.G., and not all patients had these findings;
previous studies have not found unifying radiographic findings.
11
Biopsy, therefore, is still considered the gold standard for diagnosis. Fatalities have been described in P.I.G. 2, 11 One patient in our series died. Unfortunately, this patient was lost to follow-up after initial discharge, so the cause of death is unknown. This patient had a history of congenital diaphragmatic hernia, atrial septal defect, patent ductus arteriosus, and was transferred with chronic mechanical ventilation to a facility closer to home from which he was discharged.
One of our patients also required lung transplant for pulmonary vein stenosis. Thus, these patients had significant comorbidities consistent with their severe disease course.
The role of corticosteroids in P.I.G. is controversial. A case report ; high dose regimens may not be necessary.
A large portion of patients with P.I.G. have pulmonary hypertension.
Pulmonary hypertension is a known complication of lung disease associated with early gestational age and alveolar simplification 18 and has been described in P.I.G. 19 There were significantly more pathologic findings consistent with pulmonary hypertension than by echocardiogram or cardiac catheterization. We suggest that this could be secondary to differences in timing between biopsy and pulmonary hypertension evaluation and interim resolution and/or adequate treatment of pulmonary hypertension. Histologic changes consistent with pulmonary hypertension compared to echocardiographic/cardiac catheterization findings have not systematically been evaluated for clinical correlation.
Given the significant percentage of patients with pulmonary artery changes pathologically, patients with documented P.I.G., or the P.I.G. phenotype be evaluated and followed for pulmonary hypertension.
In conclusion, we describe a phenotype of patients with P.I.G. who presented with respiratory failure and distress out of proportion to their gestational age and not explained by cardiac disease. P.I.G. is seen in association with structural heart disease, pulmonary hypertension, and/or alveolar simplification. These comorbidities may lead to persistent symptoms outside of infancy rather than the P.I.G. itself.
P.I.G. is a disease only seen in infants less than 8 months; the oldest age of pathologic findings of P.I.G. prior to the current manuscript is 5.5 months. 20 Once patients are older than 12 months, continued respiratory symptoms should be attributed to other comorbidities and treated accordingly. Although there are typical CT findings of GGO and cystic regions, 21 biopsy is required for diagnosis of P.I.G. Treatment with steroids remains controversial. Further study is needed to determine the indications for steroid therapy as well as optimal dosing, route, and duration of treatment. Despite very significant disease burden with most patients requiring mechanical ventilation, high frequency oscillation, or extracorporeal membrane oxygenation, there was only one death in our cohort. Long term pulmonary follow-up is important for these patients and outcomes overall are favorable.
